Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma
2009
Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation
2008
Hepatocellular carcinoma
2003 Standout
Liver Transplantation for Hepatocellular Carcinoma
1998
SUBCLINICAL REJECTION AND BORDERLINE CHANGES IN EARLY PROTOCOL BIOPSY SPECIMENS AFTER RENAL TRANSPLANTATION
2004
Reproducibility of the Banff schema in reporting protocol biopsies of stable renal allografts
2002
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation
2004
Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)
2003
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
2001 Standout
Peginterferon alfa‐2a for hepatitis C after liver transplantation
2005
Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation
2005
Improved Diagnostic Imaging and Interventional Therapies Prolong Survival After Resection for Hepatocellular Carcinoma in Cirrhosis: The University of Bologna Experience Over 10 Years
2010
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus
2007
Risk Factors for Development of New-Onset Diabetes Mellitus After Kidney Transplantation
2006
Surveillance for Hepatocellular Carcinoma and Early Diagnosis
2007
Hepatocellular carcinoma
2018 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency
2003
Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center
2008
The Utility of 1- and 3-Month Protocol Biopsies on Renal Allograft Function: A Randomized Controlled Study
2008
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials
2002
LIVER TRANSPLANTATION FOR CHOLANGIOCARCINOMA: RESULTS IN 207 PATIENTS1
2000
Prognostic models for outcome following liver resection for colorectal cancer metastases: A systematic review
2011
LIVING-DONOR VERSUS CADAVERIC LIVER TRANSPLANTATION FOR NON-RESECTABLE SMALL HEPATOCELLULAR CARCINOMA AND COMPENSATED CIRRHOSIS: A DECISION ANALYSIS1
2001
Irreversible Intestinal Failure
2004
Locoregional Therapy With Curative Intent Versus Primary Liver Transplant for Hepatocellular Carcinoma
2017
Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
2003
Hepatocellular carcinoma
2012 Standout
Downstaging Advanced Hepatocellular Carcinoma to the Milan Criteria May Provide a Comparable Outcome to Conventional Milan Criteria
2013
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
2010 Standout
Liver biopsy†
2008
Status of hyperthermia in the treatment of advanced liver cancer
2001
Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging
2007
Improving Safety with Information Technology
2003 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Liver grafts from anti-hepatitis B core positive donors: A systematic review
2009
Hepatocellular carcinoma: Diagnosis and treatment
2002
Percutaneous microwave ablationvsradiofrequency ablation in the treatment of hepatocellular carcinoma
2015
SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1
2001
An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data
2009
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
The application of neural networks in predicting the outcome of in- vitro fertilization
1997 Standout
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States
2009
Outcome, Incidence, and Timing of Infectious Complications in Small Bowel and Multivisceral Organ Transplantation Patients
2005
Liver Transplantation for Hepatocellular Carcinoma
2008
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted
2008
Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients
2005
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience
2011
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Chronic hepatitis B
2007 Standout
Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy
2004
Vascular Invasion and Histopathologic Grading Determine Outcome After Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis
2001
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
2008
Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation
2011
Chronic hepatitis B: Update 2009 #
2009 Standout
MR Imaging of Hepatocellular Carcinoma in the Cirrhotic Liver: Challenges and Controversies
2008
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation
2007 Standout
Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: Cohort study of 38 patients
2005
Management of HCC
2012
Recurrence After Liver Transplantation for Hepatocellular Carcinoma
2016
Biliary Tract Cancers
1999
Resection and Liver Transplantation for Hepatocellular Carcinoma
2005
The Significance of Subclinical Rejection and the Value of Protocol Biopsies
2006
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
2010
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Diagnosis and Treatment of Hepatocellular Carcinoma
2008
Clinical application of sirolimus in renal transplantation: an update
2005
Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation
2011
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Protective effect of carbon monoxide inhalation for cold-preserved small intestinal grafts
2003
Alemtuzumab (Campath 1H) Induction With Tacrolimus Monotherapy Is Safe for High Immunological Risk Renal Transplantation
2007
Application of artificial neural networks to clinical medicine
1995
MELD score predicts 1-year patient survival post-orthotopic liver transplantation
2003
Neonatal short bowel syndrome
2005
Does Donation After Cardiac Death Utilization Adversely Affect Hepatocellular Cancer Survival?
2016
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Natural History, Risk Factors, and Impact of Subclinical Rejection in Kidney Transplantation
2004
Resection of hepatocellular cancer ≤2 cm: Results from two Western centers
2012
Staging of Colorectal Cancer: Past, Present, and Future
2005
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Impact of UCSF criteria according to pre- and post-OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time
2006
Recurrent Disease Following Liver Transplantation for Nonalcoholic Steatohepatitis Cirrhosis
2009
Difference in Tumor Invasiveness in Cirrhotic Patients With Hepatocellular Carcinoma Fulfilling the Milan Criteria Treated by Resection and Transplantation
2006
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
2015
A Prospective Evaluation of Fibrosis Progression in Patients with Recurrent Hepatitis C Virus Following Liver Transplantation†
2007
Hepatocellular Carcinoma
2011 Standout
HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression
2008 Standout
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Liver transplantation for small hepatocellular carcinoma: The tumor-node-metastasis classification does not have prognostic power
1998
Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model
2001
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Surgical Management of Early-Stage Hepatocellular Carcinoma: Resection or Transplantation?
2008
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin
2006
Hepatocellular carcinoma
2022 Standout
Lack of Benefit of Early Protocol Biopsies in Renal Transplant Patients Receiving TAC and MMF: A Randomized Study
2007
The model for end-stage liver disease (MELD)
2007
Hepatitis C Virus RNA Functionally Sequesters miR-122
2015 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Genome Regulation by Long Noncoding RNAs
2012 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
1999
Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy
2009
Clinical Significance of an Early Protocol Biopsy in Living-Donor Renal Transplantation: Ten-Year Experience at a Single Center
2005
Tacrolimus
2000
Simplified Staging for Hepatocellular Carcinoma
2002
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Alemtuzumab (Campath-1H) and Tacrolimus Monotherapy After Renal Transplantation: Results of a Prospective Randomized Trial
2008
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Donor T Cell Activation Initiates Small Bowel Allograft Rejection Through an IFN-γ-Inducible Protein-10-Dependent Mechanism
2002
Long-Term Survival and Pattern of Recurrence After Resection of Small Hepatocellular Carcinoma in Patients With Preserved Liver Function
2002
Liver Transplantation for Malignancy
2005
Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis
2004
Part 8: Post–Cardiac Arrest Care
2015 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Expression of CXC Chemokine Ligand 10 from the Mouse Hepatitis Virus Genome Results in Protection from Viral-Induced Neurological and Liver Disease
2007 StandoutNobel
AASLD position paper: Liver biopsy
2008
Simplified Staging for Hepatocellular Carcinoma
2002
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
2009
Intestinal and Multivisceral Transplantation
2002
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
2005 Standout
Works of Igor Dvorchik being referenced
Prognostic Models in Hepatocellular Carcinoma (HCC) and Statistical Methodologies Behind Them
2007
Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus Monotherapy
2006
Liver transplantation for hepatocellular carcinoma: Extension of indications based on molecular markers
2008
An Analysis of Early Renal Transplant Protocol Biopsies – the High Incidence of Subclinical Tubulitis
2001
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?
2000
MELD and prediction of post–liver transplantation survival
2006
Simultaneous Administration of Adjuvant Donor Bone Marrow in Pancreas Transplant Recipients
1999
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation
1997
AN ANALYSIS OF PRETRANSPLANTATION VARIABLES ASSOCIATED WITH LONG-TERM ALLOGRAFT OUTCOME IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS (FK506) THERAPY
1999
Should we biopsy each liver mass suspicious for hepatocellular carcinoma before liver transplantation?–Yes
2005
Kidney transplantation with bone marrow augmentation: five-year outcomes
2001
Liver Transplantation Using Donation After Cardiac Death Donors: Long-Term Follow-Up from a Single Center
2009
Treatment of Hilar Cholangiocarcinoma (Klatskin Tumors) with Hepatic Resection or Transplantation
1998
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis1
2002
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients
2002
Microdissection–Based Allelotyping Discriminates De Novo Tumor From Intrahepatic Spread in Hepatocellular Carcinoma
2003
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study
1997
Should hepatomas be treated with hepatic resection or transplantation?
1999
Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection
2002
HEPATOBILIARY MALIGNANCIES
1999
Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation
1998
Liver transplantation in the treatment of hepatocellular carcinoma
1998
Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C
2006
Predicting Outcomes After Liver Transplantation A Connectionist Approach
1994
Pediatric intestinal transplantation: Historical notes, principles and controversies
2002
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system11No competing interests declared.
2000
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system11No competing interests declared.
1999
Clinical Intestinal Transplantation: A Decade of Experience at a Single Center
2001
Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation
2003
Fractional Allelic Imbalance Could Allow for the Development of An Equitable Transplant Selection Policy for Patients With Hepatocellular Carcinoma
2008
Role of liver transplantation for hepatobiliary malignant disorders
2004
Factors impacting the survival of children with intestinal failure referred for intestinal transplantation
1999
UNOSʼ POLICY ON UPGRADING PATIENTS WITH HCC AWAITING LIVER TRANSPLANTATION: TOO LITTLE TOO LATE.
2000
Clinical intestinal transplantation: a decade of a single center experience
2001
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease
2005
LIVER TRANSPLANTATION AND PREGNANCY
1999
Liver organ allocation for hepatocellular carcinoma: Are we sure?
2003
AN ANALYSIS OF PRETRANSPLANT VARIABLES ASSOCIATED WITH LONG-TERM GRAFT OUTCOME IN PEDIATRIC LIVER TRANSPLANT RECIPIENTS RECEIVING PRIMARY TACROLIMUS THERAPY
1998